PenningtonJ.A.T., ChurchH.N.. Bowes and Church's food values of portions commonly used (14th ed). Philadelphia: JB Lippincott, 1985.
2.
BarsottiG., MorelliE., Guiduc-ciA.Reversal of hyperparathyroidism in severe uremics following very low protein and low phosphorus diet. Nephron1982; 30: 310–13.
3.
BerlyneG.M., Ben-AriJ., PestD.Hyperaluminaemia from aluminum resins in renal failure. Lancet1970; 2: 494–9.
4.
ParkinsonI.S., WardM.K., KerrD.N.S.. Dialysis encephalopathy, bone disease and anemia: the aluminum intoxication syndrome during regular hemodialysis. J Clin Pathol1981; 34: 1285–94.
5.
AndressD.L., OttS.M., Malo-neyN.A., SherrandD.J.. Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure. N Engl J Med1985; 4: 468–73.
6.
AndressD.L., KnoppJ.B., Ma-lonelyN.A., CoburnJ.W., SherrardD.J.. Early deposition of bone aluminum in diabetic patients with chronic renal failure. N Engl J Med1987; 316: 292–6.
7.
SlatopolskyE., WeertsC., Lo-pez-HilkerS.Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med1986; 315: 157–61.
8.
SlatopolskyE., WeertsC., NorwoodK.Long term effects of calcium carbonate and 2.5 mEq/liter calcium dialysate on mineral metabolism. Kidney Int1989; 36: 897–903.
9.
MaiM.L., EmmetM., SheikhM.S., Santa AnaC.A., SchillerL., FordtranJ.S.. Calcium acetate, an effective phosphorus binder in patients with renal failure. Kidney Int1989; 36: 690–5.
10.
CushnerH.M., CopleyJ.B., LindbergJ.S., FoulksC.J.. Calcium citrate, a nonaluminum-con-itaining phosphate-binding agent for treatment of CRF. Kidney Int1988; 33: 95–9.
11.
SlaninaP., FrechW., EkstromL.G., LoofL., SlorachS., CedergrenA.. Dietary citric acid enhances absorption of aluminum in antacids. Clin Chem1986; 32: 539–41.
12.
SchaeferK., von HerrathD., A-smusG., UmlaufE.. The beneficial effect of ketoacids on serum phosphate and parathyroid hormone in patients with chronic uremia. Clin Nephrol1988; 30: 93–6.
13.
SchneiderH.W., KulbeK.D., WeberH., StreicherE.. In vitro and in vivo studies with a non-aluminum phosphate binding compound. Kidney Int1986; 29(Suppl 18): 120–3.
